Email this article to a friend
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
-
* Corresponding author: Blas Y Betancourt blas.yamir@cigb.edu.cu
BMC Clinical Pharmacology 2005, 5:5 doi:10.1186/1472-6904-5-5